Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06372496 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma

Study acronym: PERFORM
StatusActive, Not Recruiting
PhasePhase 4
Started2024-04-16
View on ClinicalTrials.gov ↗
The goal of this study is to assess and compare the effectiveness of fluticasone furoate/umeclidinium bromide/vilanterol trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma

Amendment record

Amended 6 times since 2024-04-15; most recent filed 2026-07-27. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-31.

2026-07-27
Amendment Study Status, Study Design, Arms and Interventions, Outcome Measures, Document Section, Participant Flow, Baseline Characteristics, Outcome Measures (Results), Adverse Events, More Information v6
2026-03-20
Amendment Study Status, Study Design, Contacts/Locations v5
2025-10-20
Amendment Study Status, Study Design v4
2025-05-16
Amendment Study Identification, Study Status, Outcome Measures, Eligibility, Contacts/Locations v3
2025-03-14
Amendment Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v2
2024-05-21
Amendment Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
2024-04-15
Original filing
Trial Details
NCT Number NCT06372496
Lead Sponsor GlaxoSmithKline
Conditions Asthma
Enrollment 1,366 participants
Start Date 2024-04-16
Primary Completion 2025-07-28 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-24